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Abstract 
Background: Neurotoxicity effects of anesthetics in different age groups is a 
major concern regarding neural injuries. It is reasonable to recognize the 
neurotoxicity risks of anesthetic drugs and their combinations.  
Materials and Methods: A total of 16 mice (Mus musculus) weighing 22 to 
30 gr were randomly divided into four drug groups (control, Ropivacaine, 
Ropivacaine + Dexmedetomidine, Ropivacaine + Dexamethasone). 24 hours 
after unilateral injection of drugs into the femoral nerve of mice, the mice were 
killed and their femoral nerve was removed. Hematoxylin-eosin tissue staining 
was used to evaluate changes in the effects of the drugs, and nerve samples 
were extracted to measure TLR4 and caspase 3 expressions. After Western 
blotting, the protein expression level was checked between different groups.  
Results: Ropivacaine in combination with dexamethasone caused less damage 
to the rat nerve cells. The combination of ropivacaine with dexamethasone 
(p=0.53 and p=0.46) compared to the combination of ropivacaine with 
dexmedetomidine relatively had better results in terms of cytotoxicity.  
Conclusion: A combination of ropivacaine with dexamethasone reduces 
neurotoxicity risk.  
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Introduction 
Induction of anesthesia is always an integral part of 
most surgeries. The use of different types of drugs to 
perform this process has different effects. Meanwhile, 
neurological damage and subsequent disorders have 
always been a concern for many anesthesiologists and 
researchers. Therefore, in the last two decades, many 
studies have been conducted on the effects of 
anesthetics on the nervous system of children and the 
elderly (1). In this regard, a large number of studies 
have discussed the potential unwanted effects of 
anesthetic drugs; both on the central neural network 
and peripheral nerve cells (2, 3). 
Ropivacaine is an amino amide that has fewer 
toxic effects than other environmental anesthetics (4, 
5). On the other hand, it has a lower lipophilic level 
than other amides, which causes it to pass through 
myelinated motor fibers, with a longer duration of 
block and longer analgesic effects than lidocaine and 
mepivacaine (6-8). 
Many studies show Dexmedetomidine alone has 
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less neurotoxic effects, possibly due to fewer effects on 
the GABA or NMDA receptor pathways (9, 10), with 
some reports about its organ protective effects 
including neuroprotection (11).  
Corticosteroids are another class of drugs whose 
anti-apoptotic effects have been discussed; while some 
reports have shown their potential effects as cognitive 
impairment in immature rodents (12, 13). 
N-Methyl-D-Aspartate (NMDA) and Gamma-
Aminobutyric Acid (GABA) are the most important 
receptors involved in the pathway of brain 
development while being among the main functional 
mechanisms of anesthetic drugs (14, 15). Possibly, 
these anesthetics might affect cellular neuro-apoptosis 
by disrupting the pathway of these receptors (16). 
Toll-like receptors (TLR4) are another category 
is cellular receptors that are introduced as an endotoxin 
detector (LPS), a cellular stressor, and a cell content-
related injury such as DNA, RNA, and the cytoplasm 
(17). 
Previous studies have discussed the role of this 
protein in nervous system damage and the formation of 
oxygen-free radicals and inflammation as the etiology 
and pathogenicity of TLR4. So, TLR4 level assay 
could be an appropriate surrogate measure in neural 
cell cytotoxicity (18). Sequential activation of caspases 
plays a central role in the execution phase of cell 
apoptosis (19). However, caspase-3 seems necessary 
for normal brain development; besides the role in 
apoptosis (20). 
Nervous system inflammation (one of the side 
effects of anesthetics) is caused by the activation of 
microglia and the presence of astrocytes along with the 
involvement of neurons (21). However, this does not 
include all cases and there are several other ways to do 
this type of cell damage (22). 
This study was designed to investigate the 
neurotoxic effects of Ropivacaine and its association 
with two dexamethasone and dexmedetomidine drugs 
after injection into the rat femoral nerve. 
 
Methods 
This study was reviewed and approved by the Research 
Ethics Committee of Shahid Beheshti University of 
Medical Sciences, with the registration code of IR. 
SBMU. RETECH.REC.1397.1030. 
For evaluating neurotoxicity of Ropivacaine, 
Dexmedetomidine, and Dexamethasone, Mice (Mus 
musculus) with a similar weight (22 to 30 gr) were 
used. Mice were kept and used according to the 
companion animal ethics (23). Four random groups of 
mice were formed (Figure 1). 
After 24 h, the mice sacrificed using gas CO2 
and the femoral nerve removed. Hematoxylin-eosin 
staining was used to evaluate changes in the effects of 
the drugs on isolated nerve tissues, and nerve samples 
extracted to measure TLR4 and Caspas3 expression.  
Radio-immuno-precipitation assay buffer 
(RIPA buffer) then extracts the protein. The expression 
levels of the proteins evaluated by electrophoresis and 
western blotting. At this stage, 20-40 μg of protein used 
for Western blotting. Image J software is used to detect 
and analyze images from Western blotting. 
Data were analyzed by Statistical Package for 
Social Sciences, version 14 (SPSS Inc., Chicago, IL, 
USA) on a Microsoft Windows-based setting. After 
testing for normality of pairwise differences with the 
Shapiro-Wilk normality test, the effect of Ropivacaine, 
Dexmedetomidine- Ropivacaine, and Dexamethasone- 
Ropivacaine on compared between groups using 




The expression of TLR4 and caspase 3 (as contributing 
factors to apoptosis induction and toxicity) were 
compared with GAPDH (as a housekeeping gene and 
baseline) in four different groups. As can be seen in 
figure 2, the expression index of caspase 3 biomarkers 
was presented based on the amount and thickness of 
the band produced on SDS gel following the western 
blot technique. Figure 3 represents the qualitative 
range of affinity of the target protein (caspase 3 
marker) to the standard GAPDH index. According to 
the electrophoresis affinity index (similar band 
thickness), the highest expression of Caspase 3 protein 
compared to GAPDH is related to Ropivacaine + 
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Dexmedetomidine composition. 
Figure 4 presents the quantification of TLR4 
biomarker based on the amount and density of the band 
produced on SDS gel, followed by the Western blot 
technique. This table presents the results of TLR4 
protein extraction 24 h after injection into the rat 
femoral nerve compared to the standard GAPDH index 
for the four groups (control, bupivacaine, bupivacaine 
+ dexamethasone, and bupivacaine + 
dexmedetomidine). 
Figure 5 shows the electrophoresis results of the 
proteins extracted on the gel. This table presents the 
qualitative range of affinity of the target protein (TLR4 
marker) by group and extraction site compared to the 
standard GAPDH index. 
 
Discussion 
Numerous studies have focused on the neurotoxicity 
effects of all kinds of anesthetic drugs. This type of 
disorder often manifests itself as damage or death in 
the cells of the neurons, resulting in different outcomes 
such as Alzheimer's, behavioral changes, and even 
transient and lasting cognitive changes (24). However, 
given the many limitations of the ability to repair the 
damaged central nervous system, it is important to 
 
Figure 1. Flowchart related to how to sample and divide the groups included in the study. 
The total number of 
mice entered in the 
experiment (n=16)
Sham group (n=4)










Ketamine 300 µl+ 
Xylazine 100 µl + 
ropivacaine 2 mg/kg 
+Dex 1 mg/kg
Ropivacaine + 
Dexamethasone group  
(n=4)
Ketamine 300 µl+ 
Xylazine 100 µl + 





Figure 2. Diagram (mean P. Value) of caspase3 expression compared to GAPDH in rat femoral nerve (24 h after 
injection) in four groups (sham, Ropivacaine, Ropivacaine + dexamethasone, and Ropivacaine + dexmedetomidine). 
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reduce the damage caused by inhibiting apoptotic 
neural cell death (25). The mechanism of this type of 
damage at the cellular level is still unclear, but what is 
being speculated about is the activation of microglia 
and the presence of astrocytes, which in turn causes 
devastating effects by involving neurons (26, 27). 
These injuries often increase the likelihood of 
disorders such as Alzheimer's by causing inflammation 
on the surface of the nervous system. A more detailed 
classification of nerve injury induction routes is 
demonstrated in Figure 6. 
Ropivacaine is a local anesthetic widely used in 
surgical procedures worldwide (28). Prescription of 
these drugs administration is associated with an 
increased inflammatory response, altered nerve 
permeability, and myotoxicity (29). This amino amide 
has toxic effects such as other environmental 
anesthetics. Therefore, it is important to consider the 
approach to reduce the toxic effects of taking this drug. 
The primary aim of the present study was to 
evaluate the neurotoxicity of Ropivacaine and 
combination with Dexmedetomidine and 
Dexamethasone in mice neural apoptosis when 
injected perineurally. Furthermore, this study was 
designed to test this hypothesis that Dexmedetomidine 
and Dexamethasone in combination with Ropivacaine 
have different effects on nerve injury in rats. Based on 
the results, it is observed that the use of ropivacaine in 
 
Figure 3. Qualitative comparison of caspase3 protein expression in rat femoral nerve for four groups (sham, 
Ropivacaine, Ropivacaine + dexamethasone, and Ropivacaine + dexmedetomidine) compared to standard GAPDH index 
protein. 
 
Figure 4. Diagram (mean P. Value) of TLR4 expression compared to GAPDH in rat femoral nerve (24 h after injection) 
in four groups (sham, Ropivacaine, Ropivacaine + dexamethasone, and Ropivacaine + dexmedetomidine). 
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combination with dexamethasone caused less damage 
to the rat nerve cells. Importantly, the combined use of 
ropivacaine with dexamethasone (p=0.53 and p=0.46) 
compared to the combination of ropivacaine with 
dexmedetomidine (p=1.158 and p=1.074) show 
relatively better conditions in terms of cytotoxicity 
 
Figure 5. Qualitative comparison of TLR4 protein expression in rat femoral nerve for four groups (sham, Ropivacaine, 
Ropivacaine + dexamethasone, and Ropivacaine + dexmedetomidine) compared to standard GAPDH index protein. 
 








































Hosseini et al.                                                         The effects of Ropivacaine and its Combination on Neural Apoptosis … 
Journal of Cellular & Molecular Anesthesia (JCMA) 
148 
(Figs. 3 and 5). Indeed, we demonstrated that the 
combined use of ropivacaine with dexamethasone 
reduces its neurotoxicity risk. An earlier study of the 
effects of clonidine and dexmedetomidine on the 
effects of ropivacaine as a local anesthetic showed that 
neurotoxicity leading to apoptosis of nerve cells 
decreased due to increased microglia activity following 
a combined administration of ropivacaine and 
clonidine. As a result, it has been shown that the use of 
ropivacaine with clonidine or dexamethasone in 
addition to improving the quality of anesthetic effects 
also reduces neural toxicity (30, 31). This type of 
change can also be seen in the central nervous system, 
with the simultaneous use of both Dexmedetomidine 
and ropivacaine increasing the quality of anesthesia 
and reducing the activity of astrocytes. It should be 
noted that the combination of these two drugs is useful 
for improving the effect of anesthesia and reducing 
inflammation in the central nervous system (31, 32). 
 
Conclusion 
Based on the results, the combined use of ropivacaine 
with dexamethasone reduces its neurotoxicity risk. 
However, the human phase of this research and closer 
scrutiny of the cellular mechanisms behind the use of 
these drugs could paint a brighter horizon for 
physicians and researchers. 
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